Who is Treating Wet AMD With Oraya Therapeutics’ IRay® Radiotherapy System?
February 12, 2013
A patient with wet age-related macular degeneration (AMD) recently wrote to us asking where he could get treated with Oraya’s new IRay Radiotherapy System, a non-invasive treatment for wet AMD that delivers low energy X-rays to the macula. The X-rays are directed into the eye while the patient sits comfortably in a chair, with the head positioned on a chin rest. No lead apron is required. The entire outpatient procedure takes about 20 minutes and the patient can go home after the appropriate post-treatment evaluations are made.
Studies have shown that, after a year, treatment with the IRay system can reduce the need for anti-VEGF injections such as Lucentis or Eylea by up to 32%.
Oraya’s website indicates that in December 2012, the company reached agreement with UK specialist eye hospital group Optegra, to establish the world’s first clinical center to offer the new radiotherapy at Optegra’s Surrey Eye Hospital in Guildford, England.
Click here to read the release.
The therapy is not yet approved for use in the United States so interested patients would need to travel to England for treatment.
We’ve previously blogged about IRay as it was under development.
You might also enjoy...
- Will the IRay Revolutionize the Treatment of Wet Macular Degeneration?
- Oraya IRay In-office Stereotactic X-ray Treatment for AMD: A First Report
- Oraya Therapeutics INTREPID Study Demonstrates Two-year Safety and Effectiveness of Non-invasive Therapy for Wet AMD
- New Radiation Treatment for AMD Starts Trial in UK
- Regeneron’s Eylea: A Game Changer for Treatment of Macular Degeneration?
Jump down to form below to submit your own comments